Ausgabe 3/2021
Supplement: Translating Genomic Medicine to Treatments (pages 613-690)
Inhalt (23 Artikel)
Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports
R. S. Soumya, T. Govindan Unni, K. G. Raghu
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
Shubham Agarwal, Sanjeev Kumar Agarwal
Major Cardiac–Psychiatric Drug–Drug Interactions: a Systematic Review of the Consistency of Drug Databases
João Mauricio Castaldelli-Maia, Caio Hofmann, Antonio Carlos Palandri Chagas, Alvaro Sosa Liprandi, Alejandro Alcocer, Laura H. Andrade, Andreas Wielgosz
The Potential of Albuminuria as a Biomarker of Diabetic Complications
Pappitha Raja, Alexander P. Maxwell, Derek P. Brazil
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease
Roy O. Mathew, Robert S. Rosenson, Radmila Lyubarova, Rafia Chaudhry, Salvatore P. Costa, Sripal Bangalore, Mandeep S. Sidhu
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Anders Hostrup Larsen, Henrik Wiggers, Ole Lindgård Dollerup, Nichlas Riise Jespersen, Nils Henrik Hansson, Jørgen Frøkiær, Kim Brøsen, Helene Nørrelund, Hans Erik Bøtker, Niels Møller, Niels Jessen
The Impairment in Kidney Function in the Oral Anticoagulation Era. A Pathophysiological Insight
Pietro Scicchitano, Marco Tucci, Maria Consiglia Bellino, Francesca Cortese, Annagrazia Cecere, Micaela De Palo, Francesco Massari, Pasquale Caldarola, Francesco Silvestris, Marco Matteo Ciccone
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia
Sergi Torramade-Moix, Marta Palomo, Manel Vera, Didac Jerez, Ana Belen Moreno-Castaño, M Urooj Zafar, Jordi Rovira, Fritz Diekmann, Joan Carles Garcia-Pagan, Gines Escolar, Aleix Cases, Maribel Diaz-Ricart
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System
Akash Kataruka, Dhruv Mahtta, Julia M. Akeroyd, Ravi S. Hira, Dhruv S. Kazi, John A. Spertus, Deepak L. Bhatt, Laura A. Petersen, Christie M. Ballantyne, Salim S. Virani
Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
Mei-Chuan Lee, Chia-Te Liao, Han Siong Toh, Chih-Chen Chou, Wei-Ting Chang, Zhih-Cherng Chen, Wen-Shiann Wu, Tsung Yu, Carol Strong
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics
Joel A. Morales-Rosado, Kashish Goel, Lingxin Zhang, Axel Åkerblom, Saurabh Baheti, John L. Black, Niclas Eriksson, Lars Wallentin, Stefan James, Robert F. Storey, Shaun G. Goodman, Gregory D. Jenkins, Bruce W. Eckloff, Suzette J. Bielinski, Hugues Sicotte, Stephen Johnson, Veronique L. Roger, Liewei Wang, Richard Weinshilboum, Eric W. Klee, Charanjit S. Rihal, Naveen L. Pereira
Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials
Avik Ray, Ahmad Najmi, Gaurav Khandelwal, Ratinder Jhaj, Balakrishnan Sadasivam
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction
Mahin R. Khan, Waleed T. Kayani, Jason Pelton, Ahmed Ansari, David Paniagua, Umair Khalid, Ali Denktas, Hameem U. Changezi, Ahmad Munir, Ernesto Jimenez, Mahboob Alam, Hani Jneid
Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway
Zhiqiang Zhao, Ruiling Li, Xinghua Wang, Jian Li, Meng Yuan, Enzhao Liu, Tong Liu, Guangping Li
TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis
Yunxiao Yang, Yifan Jia, Yu Ning, Wanwan Wen, Yanwen Qin, Huina Zhang, Yunhui Du, Linyi Li, Xiaolu Jiao, Yunyun Yang, Guanghui Liu, Mengling Huang, Ming Zhang
Translating genetic association of lipid levels for biological and clinical application
Bradley Crone, Amelia M. Krause, Whitney E. Hornsby, Cristen J. Willer, Ida Surakka
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases
Haocheng Lu, Jifeng Zhang, Y. Eugene Chen, Minerva T. Garcia-Barrio
The Interface of Therapeutics and Genomics in Cardiovascular Medicine
E. F. Magavern, J. C. Kaski, R. M. Turner, A. Janmohamed, P. Borry, M. Pirmohamed
Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
Aleesha Shaik, Robert S. Rosenson